- Medifast Inc (NYSE:MED) has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase, National Association.
- Under the agreement, Medifast will repurchase an aggregate of $100 million of its common stock.
- The buyback equates to about 600,000 shares at the closing price on May 31, 2022, representing 5% of its outstanding stock.
- The company intends to fund the ASR program using available cash on hand and borrowings under its existing credit facility.
- Medifast held $122.1 million in cash and equivalents as of March 31, 2022.
- Price Action: MED shares are trading higher by 5.16% at $175.36 on the last check Wednesday.
Griffon Corporation Declares $2/Share Special Dividend; Also Announces Debt Repayment
The Board of Directors of Griffon Corporation (NYSE:GFF) (the "Company" or "Griffon") has declared a special cash dividend of $2.00 per share payable on July 20, 2022 to shareholders of
